assessed efficacy/tolerance of IVIG and PE in acute MG exacerbation • Randomizing 87 patients to 0.4 gm/kg IVIG daily for either 3 days (N=23) or 5 days (N=23), or PE (N = 41) • Myasthenic muscular score (MSS) through day 15 as primary end-point.